申请人:Bristol-Myers Squibb Company
公开号:US20140135335A1
公开(公告)日:2014-05-15
Compounds of Formula I, including pharmaceutically acceptable salts, as well as compositions containing these compounds, have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV:
公式I的化合物,包括药用可接受的盐,以及含有这些化合物的组合物,对丙型肝炎病毒(HCV)具有活性,并可能在治疗感染HCV的患者中有用: